Valuation ASKA Pharmaceutical Holdings Co.,Ltd.

Stocks

Delayed Japan Exchange 06:06:48 11/09/2026 +04			5-day change	1st Jan Change
2,036.00 ^JPY	-1.02%		-0.63%	-0.10%

09-04	Metagen Therapeutics, Inc. announced that it has received ¥3.71 billion in funding from a group of investors	CI
08-04	ASKA Pharmaceutical Holdings Co.,Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	35,672	33,620	62,863	65,350	67,015	58,411	-	-
Change	-	-5.75%	86.98%	3.96%	2.55%	-12.84%	-	-
Enterprise Value (EV)	32,615	28,338	55,110	65,094	67,430	58,411	58,411	58,411
Change	-	-13.11%	94.47%	18.12%	3.59%	-13.38%	0%	0%
P/E	8.35x	7.92x	8.33x	12.8x	12.3x	12.5x	10.6x	9.09x
PBR	0.73x	0.62x	1.02x	1x	0.95x	0.8x	0.77x	0.72x
PEG	-	-10.51x	0.1x	-0.4x	1.98x	-0.9x	0.6x	0.6x
Capitalization / Revenue	0.63x	0.56x	1x	1.02x	0.94x	0.8x	0.78x	0.74x
EV / Revenue	0x	0x	0x	0x	0x	0.8x	0.78x	0.74x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	0x	0x	0x	0x	0x	9.19x	7.85x	6.8x
EV / FCF	0x	0x	0x	-0x	0x	16.4x	11.9x	17.1x
FCF Yield	6.13%	6.17%	5.08%	-5.57%	5.37%	6.09%	8.39%	5.84%
Dividend per Share ²	15	16	40	55	60	65	70	74
Rate of return	1.19%	1.35%	1.8%	2.39%	2.54%	3.16%	3.4%	3.6%
EPS ²	151.2	150.1	266.5	180	191.1	164.4	194.5	226.4
Distribution rate	9.92%	10.7%	15%	30.6%	31.4%	39.5%	36%	32.7%
Net sales ¹	56,607	60,461	62,843	64,139	71,127	73,124	74,955	78,479
EBITDA	13,633	8,235	9,162	7,578	-	-	-	-
EBIT ¹	4,795	5,108	6,500	5,331	5,834	6,354	7,441	8,591
Net income ¹	4,290	4,238	7,545	5,101	5,424	4,669	5,524	6,429
Net Debt	-3,057	-5,282	-7,753	-256	415	-	-	-
Reference price ²	1,263.00	1,189.00	2,219.00	2,304.00	2,360.00	2,057.00	2,057.00	2,057.00
Nbr of stocks (in thousands)	28,243	28,276	28,329	28,364	28,396	28,396	-	-
Announcement Date	12/05/22	11/05/23	10/05/24	12/05/25	11/05/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD.	12.54x	-	-	3.15%	381M
ELI LILLY AND COMPANY	32x	11.63x	23.59x	0.62%	1,002B
JOHNSON & JOHNSON	28.37x	6.53x	17.91x	2.01%	644B
ABBVIE INC.	32.13x	7.46x	15.49x	2.73%	443B
ROCHE HOLDING AG	18.9x	4.61x	11.42x	2.88%	343B
NOVARTIS AG	19.46x	5.11x	12.69x	3.2%	262B
ASTRAZENECA PLC	20.29x	4.17x	11.93x	2.12%	245B
AMGEN INC.	24.75x	6.5x	11.57x	2.58%	212B
NOVO NORDISK A/S	12.86x	4.67x	9.75x	3.91%	199B
GILEAD SCIENCES, INC.	-44.5x	6.43x	25.11x	2.26%	181B
Average	15.68x	6.35x	15.50x	2.55%	353.01B
Weighted average by Cap.	22.91x	7.53x	17.31x	2.04%